Phase IIb: Double-Blind, Randomized, Placebo Controlled, Dose-ranging Trial of BMS-927711 for the Acute Treatment of Migraine.
Phase of Trial: Phase II
Latest Information Update: 12 Aug 2013
At a glance
- Drugs Rimegepant (Primary) ; Sumatriptan
- Indications Migraine
- Focus Therapeutic Use
- 12 Aug 2013 Results published in Cephalalgia.
- 30 Jun 2013 Results presented at the 2013 International Headache Congress .
- 04 Dec 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History